Bluefield Innovations is an innovative collaboration between Deerfield Management and Johns Hopkins University, dedicated to navigating the complexities of scientific advancement from concept to commercialization. This collaboration aims to catalyze the development of early-stage therapeutics by providing funding and support. With an initial funding of up to $65 million over five years, Bluefield Innovations focuses on supporting the commercialization of early-stage therapeutic research at Johns Hopkins.

The collaboration operates with a joint steering committee, which identifies and supports research through the preclinical development process. This includes basic research, proof of concept, target selection, and investigational new drug (IND) enabling studies. By combining Johns Hopkins University's scientific discovery expertise and Deerfield's drug development, operational, and financial support, Bluefield Innovations aims to reduce the financial and developmental risks associated with early-stage novel projects.

Bluefield Innovations is driven by the belief that by pursuing big ideas and sharing knowledge, we can make the world a better place. Visit their website for more information